Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Brain Neoplasms × Cabergoline × Clear all

Sponsor

Conditions

Pituitary Neoplasms 2 Pituitary ACTH Hypersecretion 2 Prostatic Neoplasms 1 Prolactinoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Melanoma 1 Dumping Syndrome 1 Breast Neoplasms 1 Adrenocortical Hyperfunction 1 Acromegaly 1

Interventions

Temozolomide 50 Bevacizumab 42 Radiotherapy 28 Radiosurgery 18 Carboplatin 14 Erlotinib Hydrochloride 10 Radiation 9 pembrolizumab 8 Vorinostat 8 Magnetic Resonance Spectroscopy 8 Irinotecan 8 Trastuzumab 7 Radiotherapy, Intensity-Modulated 7 Etoposide 7 Capecitabine 7 Lomustine 6 Lapatinib 6 dabrafenib 5 Sunitinib 5 Sorafenib 5 Ipilimumab 5 Imatinib Mesylate 5 Everolimus 5 Cyclophosphamide 5 cabozantinib 4 binimetinib 4 Therapeutics 4 Radiotherapy, Conformal 4 NVP-BKM120 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡